| Primary information |
|---|
| ID | 1344 |
| Peptide Name | Formula 6 |
| Sequence | Orn-KD |
| Length | 3 |
| Chirality | L |
| N-terminal Modification | None |
| C-terminal Modification | None |
| Chemical Modification | Orn = Ornithine |
| Linear/ Cyclic | Linear |
| Nature | Synthetic |
| Source of Origin | NA |
| Target | Suppress the antigen presentation of macrophages or antigen recognition of T-cells in the immune processes |
| Mechanism of Action | Inhibit maturation of the T-cell dependent antibody producing cells, supress the phagocytosis and dminish the late hypersensitive response |
| In vitro/In vivo | In vitro |
| Cell Line | Splenocyte s obtained from rats |
| Inhibition Concentartion | NA |
| In vivo Model | Twelve Wistar (LATI) rats |
| Assay | Hummoral Immune Response assay |
| Lethal Dose | NA |
| Combination Therapy | NA |
| Pubmed ID | US 5093320 |
| Year of Publication | 1992 |
| 3-D Structure | NA |
